DALLAS, Feb. 7, 2019 /PRNewswire/ — North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) today announced launching its all new eCommerce site for CBD products and other cannabis essentials at WWW.USMJ.COM. The site has been live in a pre-launch mode available to USMJ partners, vendors, media and shareholders and is now open to the public. “Even in our pre-launch campaign, sales have been robust,” said Steven Rash, CEO of USMJ. “We’ve already had to re-order some stock to resupply our inventory. Sales of EVERx CBD Sports Water have been particularly high.” The WWW.USMJ.COM site includes EVERx CBD Sports Water from USMJ’s sister company, Puration Inc. (USOTC: PURA). USMJ plans to continue expanding the number and variety of products available from WWW.USMJ.COM. Kali-Extracts’ (USOTC: KALY) Hemp4mula CBD infused gum and gummies will soon be on the site in addition to Kali-Extracts own line of CBD oils. The 2019 Miss USMJ Calendar is also available at WWW.USMJ.COM. Cannabis essentials and CBD products from other specialty manufactures can also be found at WWW.USMJ.COM and USMJ plans to also continue expanding the number and variety of cannabis themed products from other specialty manufactures. USMJ’s plans for WWW.USMJ.COM are to brand the site as an essential resource for people that identify as members of the cannabis community. USMJ and the Miss USMJ Team will be soon launching a series of pop-up cannabis community events as part of the strategy to brand WWW.USMJ.COM. The first pop-up events will take place in Denver next week in partnership with WCVC’s (OTCBB: WCVC) Illegal Burger on February 13th, and 15th. Look for more details on the event to be announced soon.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Leave a Reply